1. Home
  2. TMDX vs CENX Comparison

TMDX vs CENX Comparison

Compare TMDX & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • CENX
  • Stock Information
  • Founded
  • TMDX 1998
  • CENX 1995
  • Country
  • TMDX United States
  • CENX United States
  • Employees
  • TMDX N/A
  • CENX N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CENX Aluminum
  • Sector
  • TMDX Health Care
  • CENX Industrials
  • Exchange
  • TMDX Nasdaq
  • CENX Nasdaq
  • Market Cap
  • TMDX 2.3B
  • CENX 1.9B
  • IPO Year
  • TMDX 2019
  • CENX 1996
  • Fundamental
  • Price
  • TMDX $68.58
  • CENX $18.56
  • Analyst Decision
  • TMDX Buy
  • CENX Strong Buy
  • Analyst Count
  • TMDX 10
  • CENX 3
  • Target Price
  • TMDX $118.44
  • CENX $23.00
  • AVG Volume (30 Days)
  • TMDX 929.2K
  • CENX 1.8M
  • Earning Date
  • TMDX 04-29-2025
  • CENX 04-30-2025
  • Dividend Yield
  • TMDX N/A
  • CENX N/A
  • EPS Growth
  • TMDX N/A
  • CENX N/A
  • EPS
  • TMDX 1.01
  • CENX 3.27
  • Revenue
  • TMDX $441,540,000.00
  • CENX $2,220,300,000.00
  • Revenue This Year
  • TMDX $25.24
  • CENX $11.16
  • Revenue Next Year
  • TMDX $19.89
  • CENX $3.93
  • P/E Ratio
  • TMDX $67.90
  • CENX $5.74
  • Revenue Growth
  • TMDX 82.74
  • CENX 1.60
  • 52 Week Low
  • TMDX $55.00
  • CENX $11.40
  • 52 Week High
  • TMDX $177.37
  • CENX $25.39
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 47.95
  • CENX 46.24
  • Support Level
  • TMDX $66.69
  • CENX $18.29
  • Resistance Level
  • TMDX $73.68
  • CENX $20.45
  • Average True Range (ATR)
  • TMDX 3.42
  • CENX 1.03
  • MACD
  • TMDX 0.17
  • CENX -0.05
  • Stochastic Oscillator
  • TMDX 53.89
  • CENX 45.58

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

Share on Social Networks: